Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Daily Stock Ratings & Price Targets US

Daily stock ratings from over 8,000 Wall Street analysts

Analysts' Top Stocks

Top Smart Score Stocks

Stock Screener

Daily Analyst Ratings

Trending Stocks

Penny Stocks Screener

Insider Hot Stocks

Daily Buy Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Nicholas Jones CFAJMP Securities	CSGP CoStar Group	BUY$90	25.94% Upside
Kyle VoigtKBW	NDAQ Nasdaq	BUY$91	16.85% Upside
Josh JenningsTD Cowen	SYK Stryker	BUY$435	19.65% Upside
Yi ChenH.C. Wainwright	VANI Vivani Medical	BUY$3	148.96% Upside

Daily Sell Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Alexander GoldfarbPiper Sandler	IIPR Innovative Industrial Properties	SELL$70	-4.12% Downside
Simeon GutmanMorgan Stanley	TSCO Tractor Supply	SELL$47	-12.79% Downside
Toni KaplanMorgan Stanley	FDS Factset Research	SELL$409	-15.45% Downside
Peter WelfordJefferies	NVO Novo Nordisk	SELL$81.5	-5.20% Downside

Full List of Stock Ratings

(Dec 20, 2024)

Analyst Performance

Any

Analyst Rating

Any

Upside / Downside

Any

Action

Any

Market Cap

Any

Analyst & Firm	Company	Rating & Price Target	Upside / Downside	Average Return	Action	Date	Article
Ryan ZimmermanBTIG	HUMA Humacyte	BUY $10	―	-0.50%	Reiterated	2024-12-20	BTIG Sticks to Their Buy Rating for Humacyte (HUMA)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $95→$90	―	4.90%	Assigned	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $102	―	9.00%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $330→$378	―	8.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $382→$385	―	8.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $118→$134	―	8.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $85→$95	―	8.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $698→$705	―	8.90%	Reiterated	2024-12-20
William PickeringBernstein	VRTX Vertex Pharmaceuticals	HOLD $506→$441	―	-1.30%	Reiterated	2024-12-20	Cautious Outlook on Vertex Pharmaceuticals Due to Suzetrigine's Uncertain Efficacy in DPN Trials
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $166	―	13.20%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $133→$137	―	5.20%	Reiterated	2024-12-20
Ravi ShankerMorgan Stanley	FDX FedEx	SELL $200	―	0.00%	Reiterated	2024-12-20	Cautious Outlook on FedEx: Earnings Volatility and Guidance Concerns Drive Sell Rating
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $80→$74	―	8.50%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $476	―	8.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $325→$348	―	4.60%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $97	―	8.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $90	―	8.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $71→$86	―	13.60%	Upgraded	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $90→$68	―	1.30%	Downgraded	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $67	―	1.30%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $50	―	10.60%	Upgraded	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $28	―	2.00%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $22	―	2.80%	Initiated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $27→$20	―	6.80%	Downgraded	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $16	―	10.60%	Upgraded	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $48→$2	―	0.70%	Downgraded	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD	―	13.00%	Initiated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $135	―	1.40%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $70→$72	―	16.70%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $31→$29	―	4.40%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $66	―	0.90%	Assigned	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $67	―	0.30%	Assigned	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $47	―	12.40%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $1,261	―	5.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $233→$265	―	13.20%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $169→$158	―	13.20%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $94→$142	―	13.20%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $102→$120	―	13.20%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $70→$75	―	10.50%	Assigned	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $48	―	5.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $25	―	5.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $19	―	5.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $19	―	5.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $6	―	18.10%	Downgraded	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $535	―	8.90%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $40	―	2.10%	Reiterated	2024-12-20
Chris PierceNeedham	KMX CarMax	BUY $90→$98	―	-15.40%	Reiterated	2024-12-20	CarMax's Strategic Positioning Strengthens Bullish Outlook Amid Market Improvements
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $600→$535	―	4.10%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $9→$11	―	4.60%	Reiterated	2024-12-20
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $337	―	22.40%	Assigned	2024-12-20

Rows:

Ready for the Full Picture?Your current plan limits your access to top-tier analyst ratings. Subscribe to Premium now and unlock the full range of ratings from the highest-ranked analysts on Wall Street. Don't let partial views limit your market research potential - upgrade today!

Upgrade Now Plans & Pricing